Incremental cost effectiveness of maintaining dose intensity with G-CSF as primary therapy of intermediate grade non-Hodgkin's lymphoma. Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

publication date

  • November 15, 1997

published in